Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00539656 · ClinicalTrials.gov registry record · Phase 1
Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers
A Phase 1 study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT00539656 is a Phase 1 study that was terminated before completion, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 3 participants.
The verdict
NCT00539656, a Phase 1 study, was terminated before completion, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study is to evaluate the safety of transplantation of two cord blood products, including toxicities in patients following high-dose, myeloablative chemotherapy for blood malignancies. It is also to determine if the use of two cord products results in an improvement in neutrophil engraftment.
Interventions
- BIOLOGICAL Ex vivo expansion of cord blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2007-12-20 |
| Est. Completion | 2009-10-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00539656
The ClinicalTrials.gov registry entry for NCT00539656 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ex vivo expansion of cord blood is the first listed.
NCT00539656 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00539656 about?
NCT00539656 is a clinical study titled "Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers". This study is to evaluate the safety of transplantation of two cord blood products, including toxicities in patients following high-dose, myeloablative chemotherapy for blood malignancies. It is also to determine if the use of two cord products results in an improvement in neutrophil engraftment.
What is the current status of trial NCT00539656?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2007-12-20. Estimated completion is 2009-10-20.
What interventions are being tested in trial NCT00539656?
The interventions under investigation include: Ex vivo expansion of cord blood (BIOLOGICAL).
Who is sponsoring clinical trial NCT00539656?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.